Clinical Trial Update: Evaluation of Safety and Efficacy of Nasea(R)/Ramosetron Inj. in Patients Undergoing Facial Bone Fracture Operations [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the safety and efficacy of Nasea/Ramosetron Injection in patients undergoing facial bone fracture surgery; the study status is TERMINAT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Bone Fracture

Drugs mentioned

• Nasea(R)/Ramosetron Injection (Ramosetron)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Facial Bones Fracture | Phase 4 | Status: TERMINATED